Please join Squire Sanders, BioEnterprise, BioOhio and BioOhio-member NPI for “Winning Commercialization Strategies: Paths to China” on January 24. The program will address tactical, legal and financing strategies for exporting biomedical products to China. Topics to be covered include:
Why China? Demographics and Trends
Does China Really Want Your Product? Segment and Product Assessment
Building the Foundation: Product/IP Protection, Regulatory (SFDA) and Other Legal Issues
Go-to-Market: Channel Development, Pricing and Importation
Profitable Growth: Infrastructure and Competitiveness
Commercialization Paths and Financing: Exporting v. Localization, Technology Transfer and Licensing, Joint Ventures and Funding
Speakers
John F. Lewis, Jr., Vice President & COO, BioOhio
Baiju R. Shah, President & CEO, BioEnterprise
Damon Canfield, Principal, NPI
Terry Chen, Vice President, NPI China Medical
Lisa G. Han, Partner, Squire Sanders
Case Studies
David R. Scholl, Former Senior Vice President, Commercial Operations and Former President of DHI
Ge Yan, Executive Vice President, SLS Capital Investment